Home > Personal Investment Vitae
Location: United States
Gender: Female
Asset investment style: Quantitative fundamental analysis
Market capitalization:
$8,505,225talentsVirtual portfolio value:
$5,260,271talentsNet overall return per annum:
18.73%AYA current rank order:
#18Asset investment philosophy:
Apple Boston trades U.S. stocks with the top #226 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| UBXG | U-BX Technology Ltd. Class A Ordinary Shares | $0.34 | $3.98 | 38,608 | +1,070.59% | $140,533 |
| TOP | TOP Financial Group Limited Class A Ordinary Shares | $2.06 | $16.73 | 8,215 | +712.14% | $120,514 |
| UMAC | Unusual Machines Inc. Common Stock | $1.87 | $18.73 | 7,019 | +901.60% | $118,340 |
| SXTP | 60 Degrees Pharmaceuticals Inc. Common Stock | $0.15 | $1.34 | 80,273 | +793.33% | $95,525 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 11,933 | +2,108.33% | $90,571 |
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 22,718 | +681.13% | $82,012 |
| SSNT | SilverSun Technologies Inc. Common Stock | $18.59 | $130.48 | 629 | +601.88% | $70,379 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 1,509 | +589.24% | $61,975 |
| HZNP | Horizon Therapeutics Public Limited Company Ordinary Shares | $16.41 | $98.56 | 640 | +500.61% | $52,576 |
| MRNS | Marinus Pharmaceuticals Inc. Common Stock | $1.94 | $11.62 | 3,749 | +498.97% | $36,290 |
| Sum | $868,715 |
Top 10 current stock portfolio positions as of September 2026Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| EHLD | Euroholdings Ltd. Common Stock | $11.90 | 1,869 | $22,241 |
| PXS | Pyxis Tankers Inc. Common Stock | $6.45 | 3,352 | $21,620 |
| MMED | MiniMed Group Inc. Common Stock | $23.76 | 886 | $21,051 |
| EPRX | Eupraxia Pharmaceuticals Inc. Common Stock | $7.45 | 2,781 | $20,718 |
| RGC | Regencell Bioscience Holdings Limited Ordinary Shares | $6.31 | 3,260 | $20,570 |
| TARS | Tarsus Pharmaceuticals Inc. Common Stock | $82.76 | 242 | $20,027 |
| ALNY | Alnylam Pharmaceuticals Inc. Common Stock | $267.40 | 74 | $19,787 |
| NVA | Nova Minerals Limited American Depositary Shares | $5.66 | 3,468 | $19,628 |
| LUMN | Lumen Technologies Inc. Common Stock | $6.81 | 2,874 | $19,571 |
| EIKN | Eikon Therapeutics Inc. Common Stock | $11.38 | 1,717 | $19,539 |
| Sum | $204,752 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Dan Rochefort | @Andy Yeh Alpha | ||
| @Daisy Harvey | |||
| @Laura Hermes | |||
| @Charlene Vos | |||
| @Chanel Holden |
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Cloud Play | @TechBull22 | @Ru-Ting Yeh | @Syl_will |
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
2020-10-13 08:27:00 Tuesday ET
Agile lean enterprises strive to design radical business models to remain competitive in the face of nimble startups and megatrends. Carsten Linz, Gunter
2023-01-03 09:34:00 Tuesday ET
USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved
2019-08-28 14:46:00 Wednesday ET
Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy. Cohen fin
2018-04-02 07:33:00 Monday ET
China President Xi JinPing tries to ease trade tension between America and China in his presidential address at the annual Boao forum. In his vulnerable att
2018-07-25 11:41:00 Wednesday ET
President Trump hails and touts America's new high real GDP economic growth in 2018Q2. The U.S. is now a $20+ trillion economy, and America hits this mi
2019-02-04 07:42:00 Monday ET
Federal Reserve remains patient on future interest rate adjustments due to global headwinds and impasses over American trade and fiscal budget negotiations.